CTIS2023-505584-36-00招募中1 期
A Phase 1 Study of JNJ-88549968, a T-cell Redirecting Antibody, for CALR-mutated Myeloproliferative Neoplasms
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 95
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
不适用
A Phase 1 Study of JNJ-78278343, a T Cell Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancerprostate carcinoma10038597Prostate cancerNL-OMON53995Janssen-Cilag25
进行中（未招募）
1 期
A study of JNJ-80038114 in participants with advanced stage prostate cancerProstate cancerCancerISRCTN16457874Janssen-Cilag International NV49
已完成
1 期
A Study of JNJ-79032421 Targeting Mesothelin for Advanced Stage Solid TumorsAdvanced Stage Solid TumorsNCT06255665Janssen Research & Development, LLC35
已完成
1 期
A Study of JNJ-80038114 in Participants With Advanced Stage Prostate CancerProstatic NeoplasmsNCT05441501Janssen Research & Development, LLC39
已完成
1 期
A Study of JNJ-78306358 in Participants With Advanced Stage Solid TumorsNeoplasmsNCT04991740Janssen Research & Development, LLC39